CAPITOLO VII
BIBLIOGRAFIA
1. Papadimitrakopoulou VA. Carcinogenesis of head and neck cancer and the role of chemioprevention in its reversal. Curr Opin Oncol 2000; 12: 240-5.
2. Armstrong W, Meyskens FI. Chemioprevention of head and neck cancer. Otolarynngol Head and Neck Surg 2000; 122: 728-35.
3. Almadori G, Bussu F, Galli J, et al. Serum Folate and Homocysteine Levels in Head and Neck Squamous Cell Carcinoma. Cancer 2002;
94:1006-1011.
4. Blount BC, Ames BN. DNA damage in folate deficiency. Bailleres Clin Haemato 1995; 8:461-478.
5. Blount BC, Mack MM, Wehr CM, Macgregor JT, Hiatt RA, Wang G, Wickramasinghe, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage, implications for cancer and neuronal damage.Proc. Natl Acad. Sci 1997; 94:3290-3295.
6. Eto I, Krumdieck CL. Role of vitamin B12 and folate deficiencies in
carcinogenesis. Adv Exp Med Biol 1986; 206:313-330.
7. Weinstein SJ, Gridley G, Harty LC, et al. Folate Intake, Serum Homocysteine and Methylenetetrahydrofolate Reductase (MTHFR) C677T Genotype are not Associated with Oral Cancer Risk in Puerto Rico. J Nutr 2002; 132:762-767.
8. Almadori G, Bussu F, Galli J, et al. Serum Levels of Folate, Homocysteine, and Vitamin B
12in Head and Neck Squamous Cell Carcinoma and in Laryngeal Leukoplakia. Cancer 2005; 103:284- 292.
9. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.
JAMA 1993; 270:2693-2698.
10. Oikawa S, Murakami K, Kawanishi S. Oxidative damage to cellular and isolated DNA by homocysteine: implication for carcinogenesis.
Oncogene 2003; 22:3530-3538.
11. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case- control study. Br J Cancer 1999; 79:1917-1921.
12. Alberg AJ, Selhub J, Shah KV, et al. The risk of cervical cancer in
relation to serum concentration of folate, vitamin B12 and
homocysteine. Cancer Epidemiol Biomark Prev 2000; 9:761-764.
13. Wu K, Helzlsouer KJ, Comstock GW, et al. A prospective study on folate, B12, and pyridoxal 5’-phosphate (B6) and breast cancer.
Cancer Epidemiol Biomarkers Prev 1999; 8:209-217.
14. Stolzenberg-Solomon RZ, Albanes D, Nieto et al. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999; 91:535-541.
15. Piyathilake CJ, Macaluso M, Hine RJ, et al. Cigarette smoking, intracellular vitamin deficiency, and occurrence of micronuclei in epithelial cells of buccal mucosa. Cancer Epidemiol Biomarkers Prev. 1995; 4:751-758.
16. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 1997; 33(7): 1075- 107.
17. Molinari R, Cantù G, Chiesa F. Neoplasie del distretto cervico- facciale. In: Trattato di Chirurgia Oncologica di Veronesi V. UTET 1989.
18. Parkin D M, Bray F, Pisani J F, Pisani P. Global Cancer Statistics2002. American Cancer Society 2005; 55:74-108.
19. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38:
99-166.
20. Moriniere S. Epidemiology of head and neck cancer. Rev Prat 2006; 56(15):1637-41.
21. Bosetti C, Garavello W, Levi F, Lucchini F, Negri E, La Vecchia C. Trends in laryngeal cancer mortality in Europe. Epidemiology 2006; 119(3): 673-681.
22. Wake M. The Urban/rural divide in head and neck cancer: the effect of atmospheric pollution. Otoryngol 1993;18: 298-302.
23. Tavani A, Negri E, Franceschi S, Barbone F, La Vecchia C.
Attributable risk for laryngeal cancer in Northern Italy. Cancer Epidemiol. Biomakers Prev 1994; 3:121-125.
24. Blot WJ, McLaughlin JK, Winn DM, Austin DE, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48(11) 3282-7.
25. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993; 328(3): 184-94.
26. Bonnie S. Glisson. Head and Neck Cancer. Curr Opin Oncol 2000; 12:205.
27. Maier H, Dietz A, Gewelke U, Heller WD, Weidauer H.
Tobacco and alcohol and the risk of head and neck cancer. Clin
Investig. 1992; 70(3-4):320-7.
28. Boffetta P, Richiardi L, Esteve J, Pisani P, Crosigani P, Raymond L, Zubiri L, Del Moral A, Lehmann W, Donato F, Terracini B, Tuyns A, Merletti F. Occupation and larynx and hypopharynx cancer: an international case-control study in France, Italy Spain and Switzeralnd.
Cancer Causes Control 2003; 14(3): 203-12.
29. Tumino R, Vicario R. Head and neck cancer: oral cavity, pharynx, and larynx. Epidemiol Prev 2004; 28(2 Suppl):28-33.
30. Dobrossy L. Epidemiology of head and neck cancer: Magnitude of the problem. Cancer and Metastis Rew 2005; 24: 9-17.
31. Cianci R, Galli J, Agostino S, Bartolozzi F, Gasbarrini A, Almadori G, D’ugo D, Gasbarrini G, Cammarotta G. Gastric surgery as a long-term risk factor for malignant lesions of the larynx. Arch Surg 2003;
138(7):751-4.
32. Bacciu A, Mercante G, Ingegnoli A, Bacciu S, Ferri T. Reflux esophagitis as a possibile risk factor in the development of pharyngolaryngeal squamos cell carcinoma. Tumori 2003; 89(5): 485- 7.
33. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Licttsteiner S, Wright WE. Extension of span by introduction of telomerase into normal human cells. Science 1998;
279:349-352.
34. Gallus S., Bosetti C., Franceschi S., Levi F., Simonato L., Negri E., LaVecchiaC. Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br. J. Cancer, 85: 341-345,2001.
35. International Agency for Research on Cancer. Tobacco, Smoke and I voluntary smoking. IARC Monography on the Evalutaion of Carcinogenetic Risks to Humans 2003. Volume 83.
36. Wogan GN, Hecth SS, Felton JS, Conney AH, Loeb. Environmental and chemical carcinogenesis. Semin Cancer Biol. 2004;14(6): 473- 86.
37. Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, et al. Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Nati Cancer Inst. 1991;
83(14): 1024-7.
38. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21(48):
7435-51.
39. Osada H, Takahashi T. Genetic Alerations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 2000; 21(48): 7421:34.
40. Rothman KJ, Cann CI, Flanders D, Fried MP. Epidemiology of
laryngeal cancer.Epidemici Rev. 1980; 2:195-209.
41. La Vecchia C, Bidoli E, Barra S, D’Avanzo B, Negri E, Talamini R, Franceschi S. Type of cigarettes and cancers of the upper digestive and respiratory tract. Cancer Causes Control 1990; 1:69-74.
42. Altieri A, Bosetti C, Talamini R, Gallus S, Franceschi S, Levi F, Dal Maso L, Negri E, La Vecchia C. Cessation of smoking and drinking and the risk of laryngeal cancer. Br J Cancer 2002; 87(11): 1227-9.
43. Tuyns AJ, Esteve J, Raymond L, Berrino F, Benhamou E, Blanchet F, Moffetta P, Crosignani P, del Moral A, Lehmann W et al. Cancer of the larynx/hypopharynx, tabacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). In J Cancer 1988; 41(4):483-91.
44. International Agency far Research on Cancer. Evaluation ofthe carcinogenic risk of chemicals to humans: tobacco smoking. WHO IARC Monographs 1986; 38.
45. Gupta PC, Ray CS. Smokeless tobacco and health in India and South Asia. Respirology 2003; 8(4): 419-31.
46. Johnson NW. Tobacco use and oral cancer : a global perspective. J Dent Educ 2001; 65:329-339.
47. Poschl G, Seitz Hk. Alcohol and cancer. Alcohol Alcohol. 2004;
39(3):155-65.
48. Brugere J, Guenel P, Leclere A, Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth.
Cancer 1986; 57 (2): 391-395.
49. Seitz HZ, Poschl G, Simanowski UA. Alcohol and Cancer. Recent Dev Alcohol 1998; 14:67-95.
50. Doll R, Forman D, La Vecchia C. Alcoholic beverages and cancer of the digestive tract and larynx. In: Health Issues related to Alcohol consumption, 2
ndedn, Mac Donald, 351-393. MPG Books, Bodmin Canceral
51. Garavello W, Bosetti C, Gallus s, Maso LD, Negri E, Franceschi S, La Vecchia C. Type of alcholic beverage and the risk of laryngeal cancer . Eur J Cancer Prev 2006; 15(1):69-73.
52. Schottenfield D et al. Alchol as a co-factor in the aetiology of cancer. Cancer 1979;43:1962.
53. Maier H, Weidauer H, Zoller J, Seitz HK, Flentjie M, Mall, Born IA.
Effect of chronic alcohol consumption on the morphology of the oral mucosa. Alcoholic Clin Express 1994; 18(2): 387-99.
54. Liu C, Chung J, Seitz HZ, Russell RM, Wang XD. Chlormethiazole treatment prevents reduced hepatic vitamin A levels in ethanol-fed rats. Alcohol Clin Exp Res.2002; 26(11):1703-9.
55. Obe G, Jonas R, Schimdt S. Metabolism of ethanol in vitro produces
a compound which mutagenic. MutatRes. 1986; 174(1):47-51.
56. Dellarco VL. Amutagenicity assessment of acetaldehyde. Mutas Res 1988;
195(1):1-20.57. Helander A, Lindahl-Kiesslingk. Incresead Frequency of Acetaldeyde Induced sister-Chromatin exchangesin Human Lymphocytes treated with and Aldehyde dehydrogenase inhibitor.
Mutat Res 1991; 264(3): 103-7.
58. Fang YR, Wang Zc, Muramatsu T, Yan H, Harada S,Kono H, et al.
Alohol and aldehyde dehydrogenase genotypes and drinking behavior of Chinese living in Shanghai. Hum Genet 1995; 96(2):
151-154.
59. Espina N, Lima V, Lieber CS, Garro AJ.In vitro and in vivo inhibitory effect of ethanol and acetaldehyde on O6- methylguanintransferase. Carcinogenesis. 1988; 9(5):761-6.
60. Crabb DW, Pinairs, Hasanadka R, Fang M, Leo MA, Lieber CS, et al. Alcohol and retinoids. Alcohol Clin Exp Res 2001; 25 (5 suppl ISBRA): 207S-217S.
61. Poljak M. Gale N. Kambic V. Human papillomavirus: a study of their prevalence in the epithelial hyperplastic lesions. Acta otolarynol 1997; (Suppl 527):52-6.
62. Jenison SA, Yu XP, Valentine JM, Koutsky LA, Christiansen
AE.et al. Evidence of prevalent genitalty pehuman
papillomavirus infections in adults and children. J Infect Dis.
1990; l62(l):60-9.
63. Park NH, Min BM, LiSL, Huang MZ, et al. Immortalization of normal human oral Keratinocytes with type 16 human papillomavirus.
Carcinogenesis 1991; 12(9):1627-31.
64. Woods KV, Shillitoe EJ, Spitz MR, Shantz SP, Adler-Storthz K.
Analysis of papillomavirus DNA in oral squamous cell carcinomas.J Oral Pathol Med.1993; 22(3): 101-8.
65. Almadori G, Cadoni G, Maurizi M, Ottaviani F, Plaudetti, CattaniP, Scambia. Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infection. Acta Othorhinolaryngol 1995;
15(1 suppl 46):1-22.
66. Sugar J. Vereczkey I, Toth J et al. New aspects in the pathology of the preneoplastic lesions of the larynx. Acta Otolaryngol 1997; Suppl 527: 52-6.
67. Ragin CC,Modugno F, Gollin SM. The epidemiology and risk factors of heads and neck cancer: a focus on human pappilomavirus.
J Dent Res. 2007; 86(2):104-14.
68. Intenational Agency for Research on Cancer. Tobacco smoking.
IARC Monogr Eval Carcinog Risk Chem Hum 1986; 38: 35-394.
69. Intenational Agency for Research on Cancer. Alcohol drinking.
IARC Monogr Eval Carcinog Risk Chem Hum 1988; 44:153-250.
70. Pelucchi C,Talamini R, Levi F, Bosetti C, La Vecchia C, Negri E, Parpinel M, Franceschi S. Fibre intake and laryngeal cancer risk Ann Oncol 2003; 14:162-167.
71. Garavello W, Randi G, Bosetti C, Dal Maso L, Negri E, Barman L, Franceschi S, La Vecchia C. Body size and laryngeal cancer risk.
Ann Oncol 2006; 17(9):1459-63.
72. Bosetti C, La Vecchia C, Talamini R, Negri E, Levi F, Fryzek J, McLaughlin J K,Garavello W, Franceschi S. Energy, macronutrients and laryngeal cancer risk. Ann of Oncology 2003. 14(6):907-912.
73. Slavin KA, Potter JD.Vegetables, fruit, and cancer. II. Mechanisms.
Cancer Causes Control 1991; 2:427-442.
74. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6:164-179.
75. Lipworth L., Martinez M. E., Angeli J., Hsieh C. C., Trichopoulos D.
Olive oil and human cancer: an assessment of the evidence. Prev. Med 1997; 26:181-190.
76. Boffetta P, Richiardi L, Berrino F, Esteve J, Pisani P, Crosignani P, Raymond L, Zubiri L, Del Moral A, Lehmann W, Donato F, Terracini B, Tuyns A, Merletti F. Occupation and larynx and hypoharynx cancer: an international case-control study in France,Italy,Spain, and Switzerland. Cancer Causes Control 2003;
14(3):203-12.
77. Frangez I, GaleN. Luzar B. The interpretation of leukoplachia in laryngeal pathology. Acta Otolaryngol 1997; Suppl 527:142-44.
78. Alajmo. Otorinolaringoiatria. Edizione Piccin 1995.
79. Du Vigneaud V. Trail of research in sulfur chemistry and metabolism and related fieldes. Ithaca, NY, Cornell University Press 1952.
80. Mudd SH, Skovby R, Levy HL, et al.: The natural history of homocystinuria due to cystathionine-Beta-syntetase deficiency. Am I Hum Genet 1985; 37:1-31.
81. Mc Cully KS.Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am I Pathol 1969; 561:11- 28.
82. Selhub J, Miller JW. The patogenesis of homocysteinemia:
interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and trans sulfuration of homocysteine. Am j Clin Nutr 1992; 55(1):131-8.
83. Finkelstein JD, Martin J. Methionine metabolism in mammals:
adaptation to methionine excess. J Biol Chem 1986; 261:1582-7.
84. Selhub J, Jacques PF,Wilson PW, Rush D, Rosenberg IH. Vitamin
status and intake as primary determinants of homocysteinemia in an
elderly population. JAMA 1993; 270:2693-8.
85. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high performance liquid chromtography with fluorescence detection. J Cromatogr 1987; 422:43-52.
86. Welch GN, Loscalzo J. Homocysteine and atherotrombosis. NEng U Med 1998; 338(15):1042-50.
87. Mudd SH, Levy HL, Skovby F. Disorder of transsulfuration. In:
Scriver CR, Beaudet AL, Sly WS, Valle D, Scriver CR, BeaudetAL, Sly WS, Valles D (Ed.). The metabolic basis of inherited disease.
New York: McGraw-Hill Inc.; 1995. p. 1279.
88. Frosst P,Blom HJ,Milos R,Goyette P, Sheppard CA,Matthews RG,Boers GHJ,den Heijer M,Kluijtmans Laj, van den Heuvel LP, Rozen R. Identification of a candidate genetic risk factor for vascular disease: a common mutation at the methylenetetrathydrofolate reductase locus. Nat Genet 1995; 10:111.
89. Ebbsen LS. Hyperhomocysteinemia, thrombosis and vascular biology. Cell Mol Biol (Noisy-le-grand) 2004; 50:917-930.
90. Lopez- Quesada E, Vilaseca MA, Lailla JM. Plasma total homocysteine in uncomolicated pregnancy and in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 108:45-9.
91. Yeromeneko Y., Lavie L, Levy Y. Homocysteine and cardiovascolar
risk in patients with diabetes mellitus. Nutr Metab Cardiovasc Dis
2001; 11:108-16.
92. Giovannucci E. Epidemiologic studies of folate and colonrectal neoplasia. A review. J Nutr 2002; 132:2350-5.
93. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M. Pancreatic cancer risk and nutrition- related methyl-group availability indicators in male smokers. J Natl Cancer Inst 1999; 91:535-41.
94. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE. Plasma folate,vitamine B
6, vitamine B
12,homocysteine , and risk of breast cancer. J Natl Cancer Inst 2003; 95: 373-380.
95. Goodman MT, McDuffie K, Hernandez B, Wilkens LR, Selhub J.
Case-control study of plasma folate, homocysteine, vitamine B
12and cysteine as markers of cervical dysplasia. Cancer 2000; 89:376-382.
96. Almadori G, Bussu F, Galli J, et al. Serum Levels of Folate, Homocysteine, and Vitamin B
12in Head and Neck Squamous Cell Carcinoma and in Laryngeal Leukoplakia. Cancer 2005; 103:284- 292.
97. Willis L, Mehta MM: Studies in “pernicias anaemia” of pregnancy, I preliminary report. Indian Journal of Medical Research 1930;
17:777-15.
98. Willis L: Treatment of «pernicias anaemia of pregnancy» and
"tropical anaemia» with special reference to yeast extract as curative agent. Br Med 3 1931; 1:1059-63.
99. Angier RB, Boothe JH, Hutchings BL, et al.: Synthesis of a compound identical with the L. casei factor isolated from liver.
Science 1945; 102:227-30.
100. Feldkamp M, Friedrichs M, Carey JC.: Decreasing prevalence of neural tube defects in Utah, 1985-2000. Teratology 2002; 66 S.l:
S23-8.
101. Persad VL, Van den Ho/MC, Dubé IM, et al.: incidence of open neural tube defects in Nova Scotia after folic acid fortification.
CMAI 2002; 167:241-6.
102. Ray JG, Meier C, Vermeulen MJ, Boss S, et al.: Association of neural tube defects and folic acid food fortification in Canada.
Lancet. 2002; 360:2047-8.
103. Erickson JD: Folic acid and prevention of spina bifida and anencephaly. 10 years after the U.S. Public Health Service recommendation. MMWR Recomm Rep. 2002; 51:1-3.
104. Hankey CI, Eikelboom JW.: Homocysteine and vascular disease.
Lancet 1999;354:407-15.
105. Torres OA, Miller VS, Buist NM, Hyland K.: Folinic acid-
responsive neonatal seizures. J Child Neurol. 1999; 14: 529-32.
106. Taylor MJ, Carney S, Geddes 3, Goodwln G.: Folate for depressive disorders. Cochrane Database Syst Rev 2003;(2): 33- 90.
107. Malouf R, Grimley Evans 3, Areosa Sastre A.: Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev 2003; 4:4-14.
108. Almadori G, Bussu F, Galli J, Cadoni G, Zappacosta B, Persichilli S, Minacci A, Giardina B. Serum folate and Homocysteine levels in Head and Neck Squamos Cell Carcinoma. American Cancer Society 2002;
109. Green R, Miller JW.: Folate deficiency beyond megaloblastic, anemia: hyperhomocysteinemia and other manifestations of dysfunctional folate status. Seminare in Hematology 1999; 36:47- 51.
110. Giovannucci E.: Epidemiologic studies of folate and colorectal neoplasia. A review.J Nutr 2002; 132: 2350-5.
111. Coppola A, Di Mimmo G.: L'uso farmacologico dei folati prospettive attuali. Riv.It. Ost. Gin. 2004; 1: 21-25.
112. Ludwig M V, R G Matthews. Structure based perspective on B12
depedent enzymes. Annu Rev Biochem 1997; 66:269-313.
113. Carmel R.Current concepts in cobalamin deficiency. Annu Rev Med 2000; 51:357.
114. Jacques PF et al: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N England J Med 1999; 340:1449.
115. Metz J.Cobalamin deficiency and the pathogenesis of nervous system disease. Annu Rev Nutrition 1992;12:59-79.
116. Rebbeck TR. Molecular epidemiology of the human glutathione S- transferase genotypes GSTM1 and GSTT1 in cancer susceptibility.
Cancer Epidemiol Biomarkers Prev 1997; 6:733-743.
117. Zheng Z, Park JY, Guillemette C, Scantz SP, Lazarus P. Tobacco carcinogen detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk. J Natl Cancer Inst 2001; 93:1411-1418.
118. Ames B.N., Gold L.S. and Willett W.C. The causes and preventionof cancer. Proc. Natl Acad Sci 1995.98; 5258-5265.
119. Mendelsohn M.L. An introduction to biological dosimetry. In GledhilLB-L. and Mauro F. (eds), New Horizons in Biological Dosimetry Progress in Clinical and Biological Research, Wiley- Liss Publications 1991; 372:1-10.
120. Holiday R. The inheritance of epigenetic defects. Science 1987;
238:163-170.
121. Pancharuniti,N., Lewis,C.A., Sauberlich,H.E. et al. Plasma homocysteine, folate and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am. J. clinn. Nutr. 1994; 940- 948.
122. MacGregor J.T. Dietary factors affecting spontaneous chromosomal damage in man. In Pariza M.W., Aeschbacher H.U., Felton J.S. and Sato S. (eds), Mutagens and Carcinogens in the Diet. Progress in Clinical and Biological Research 1990; 347, pp. 139-153.
123. Giovannucci E, Stampfer M.J, Colditz G.A, Rimm E.B., Trichopoulos D, Rosner B.A, Speizer F.E. and Willett W.C. Folate, methionine and alcohol intake and risk of colorectal adenoma. J. Nat Cancer Inst 1993; 85:875-882.
124. Krumdieck C.L. Localised folate deficiency and cancer. In Laidlaw S.A. and Swendseid M.E. (eds) Vitamins and Cancer Prevention 1991; 39-49.
125. Ames BN: DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res 2001; 475:7-20.
126. Fenech M: Biomarkers of genetic damage for cancer epidemiology.
Toxicology 2002; 181-182:411-416.
127. Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP,
James SJ. Uracil misincorporation, DNA strand breaks, and gene
amplification are associated with tumorigenic cell transformation in
folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 1999; 146:35-44.
128. Fenech M. The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutation Research 2001; 475:57-67.
129. Blount BC, Ames BN. DNA damage in folate deficiency. Bailleres Clin Haematol 1995; 8:461-478.
130. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA,Wang G, Wickramasinghe SN, Everson RB, and Ames BN. Folate deficiency causes uracile misincorporation into human DNA and chromosome breakage, implications for cancer and neuronal damage. Prc. Natl acad Sci 1997; 94:3290-3295.
131. Green G. and Jacobsen D.W. Clinical implication of hyperhomocysteinemia. In Bailey,L.E. (ed.), Folate in Health and Disease .Marcel Dekker 1995; 75-122.
132. Fenech M. and Morley A.A. Measurement of micronuclei inlymphocytes. Mutat. Res. 1985; 147:29-36.
133. Li YN, Gulati S, Bakerf J, Brody LC, Banerjee R. Kmger WD.
Cloning, mapping and RNA analysis of the human methionine synthetase gene . Hum Mol Genet 1996; 5:1851-1858.
134. Scott JM, Weir DG. Folic acid, homocysteine and one-carbon
metabolism: a review of the essential biochemistry. J Cardiovasc
Risk 1998; 5:223-227.
135. Fenech M, Dreosti IE, Rinaldi JR. Folate, Vitamin B12, Homocysteine status and chromosome damage rate in lymphocytes of older men, Carcinogenesis 1997; 18(7):1329-1336.
136. Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol. 2004;
10:1699-1708. Review.
137. Kane MA. The role of folates in squamous cell carcinoma of the head and neck. Cancer Detect Prev 2005; 29:46-53.
138. Weinstein SJ, Gridley G, Harty LC, et al. Folate Intake, Serum Homocysteine and Methylenetetrahydrofolate Reductase (MTHFR) C677T Genotype are not Associated with Oral Cancer Risk in Puerto Rico. J Nutr 2002; 132:762-767.
139. Giovannucci E, Ascherio A, Rimm EB, et al. Alcohol, low methionine, low folate diets and risk of colon cancer in man. J Natl Cancer Inst 1995; 87:239-240.
140. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case- control study. Br J Cancer 1999; 79:1917-1921.
141. Saito M, Kato H et al. Chemoprevention effects on bronchial squamous metaplasia by folate and vitamin B12 in heavy smokers.
Chest 1994; 106:496-499.
142. Wu K, Helzlsouer KJ, Comstock GW, et al. A prospective study on folate, B12, and pyridoxal 5’-phosphate (B6) and breast cancer.
Cancer Epidemiol Biomarkers Prev 1999; 8:209-217.
143. Alberg AJ, Selhub J, Shah KV, et al. The risk of cervical cancer in relation to serum concentration of folate, vitamin B12 and homocysteine. Cancer Epidemiol Biomark Prev 2000;9:761-764.
144. James SJ, Miller BJ, Basnakian AG, et al. Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats. Carcinogenesis 1997;18:287- 293.
145. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.
JAMA 1993;270:2693-2698.
146. Scafato E: Epidemiology of alcohol consumption among women.
Ann Ist Super Sanita 2004; 40(1):25-33.
147. Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol. 2004;
10:1699-1708. Review.
148. Sobczak A. The effects of tobacco smoke on the homocysteine level
a risk factor of atherosclerosis. Addict Biol. Review. 2003; 8:147-
158.
149. Chamberlain KL. Homocysteine and cardiovascular disease: a review of current recommendations for screening and treatment. J Am Acad Nurse Pract 2005; 17:90-95.
150. Kraunz KS, Hsiung D, McClean MD et al. Dietary folated associated with p16(INK4A) methylation in head and neck squamous cell carcinoma. Int J Cancer 2006; 119:1553-7.
151.
